Open access journal of the Ferrata-Storti Foundation, a non-profit organization
Letters to the Editor

Prognostic relevance of variant allelic frequency for treatment outcomes in patients with acute myeloid leukemia: a study by the Spanish PETHEMA registry

Hematology Department, Hospital Universitario 12 de Octubre, i+12, CNIO, CIBERONC, Complutense University, Madrid
Hematology Department, Hospital Universitario 12 de Octubre, i+12, CNIO, CIBERONC, Complutense University, Madrid
Molecular Biology Unit, Hospital Universitari i Politecnic-IIS La Fe, Valencia
Hematology Department, Hospital Universitari i Politecnic-IIS La Fe, CIBERONC, Valencia
CIMA LAB Diagnostics-Universidad de Navarra, Pamplona
Hospital Universitario de Salamanca (HUS/IBSAL), CIBERONC and Center for Cancer Research-IBMCC (USAL-CSIC), Salamanca
Hospital Universitario Virgen del Rocio, Instituto de Biomedicina (IBIS / CSIC / CIBERONC), Universidad de Sevilla, Sevilla
Hospital Universitario de Gran Canaria Dr. Negrin, Las Palmas de Gran Canaria
IMIBIC, Hematology, Hospital Universitario Reina Sofia, UCO, Cordoba
Hospital Universitario Central de Asturias, Instituto Universitario (IUOPA), Instituto de investigacion del Principado de Asturias (ISPA), Oviedo
Hematology Department, Hospital Universitari i Politecnic-IIS La Fe, CIBERONC, Valencia
Hospital General Universitario de Alicante, Alicante
IMIBIC, Hematology, Hospital Universitario Reina Sofia, UCO, Cordoba
Hospital Universitario de Gran Canaria Dr. Negrin, Las Palmas de Gran Canaria
Hospital Universitario San Pedro de Alcantara, Caceres
Hospital Universitario Virgen del Rocio, Instituto de Biomedicina (IBIS / CSIC / CIBERONC), Universidad de Sevilla, Sevilla
Hematology Department, Hospital Universitario 12 de Octubre, i+12, CNIO, CIBERONC, Complutense University, Madrid
Hospital Universitario Fundacion Jimenez Diaz, Madrid
Research Unit, Hematology Department, Hospital Universitario de Burgos, Universidad Isabel I, Burgos
Hematology Department, Hospital Clinico Universitario-INCLIVA, Valencia
Hospital Universitario Ramon y Cajal, Madrid
Instituto de Investigacion Hospital 12 de Octubre, i+12, Madrid
Hematology Department, Hospital Universitario 12 de Octubre, i+12, CNIO, CIBERONC, Complutense University, Madrid
Hematology Department, Hospital Universitario 12 de Octubre, i+12, CNIO, CIBERONC, Complutense University, Madrid
Molecular Biology Unit, Hospital Universitari i Politecnic-IIS La Fe, Valencia
CIMA LAB Diagnostics-Universidad de Navarra, Pamplona
CIMA LAB Diagnostics-Universidad de Navarra, Pamplona
Hospital Universitario de Gran Canaria Dr. Negrin, Las Palmas de Gran Canaria
Hospital Universitario de Salamanca (HUS/IBSAL), CIBERONC and Center for Cancer Research-IBMCC (USAL-CSIC), Salamanca
Hematology Department, Hospital Universitari i Politecnic-IIS La Fe, CIBERONC, Valencia
Hematology Department, Hospital Universitario 12 de Octubre, i+12, CNIO, CIBERONC, Complutense University, Madrid
Hematology Department, Hospital Universitario 12 de Octubre, i+12, CNIO, CIBERONC, Complutense University, Madrid
Hematology Department, Hospital Universitari i Politecnic-IIS La Fe, CIBERONC, Valencia
Collaborative group: PETHEMA Group ()
Haematologica Early view Feb 27, 2025 https://doi.org/10.3324/haematol.2024.286311

Abstract

Not available.

Figures & Tables

Article Information

Early view : Letters to the Editor
 
DOI
https://doi.org/10.3324/haematol.2024.286311
Pubmed
40013390
 
Published
2025-02-27
Published By
Ferrata Storti Foundation, Pavia, Italy
Print ISSN
0390-6078
Online ISSN
1592-8721
 
Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Article Usage

Online Views
120
PDF Downloads
55

Statistics from Altmetric.com

No Data
Navigate
For Authors
For Reviewers
For Advertisers
Education
Privacy
More
Copyright © 2025 by the Ferrata Storti Foundation | Web design ￫ | Development ￫
ISSN 0390-6078 print | ISSN 1592-8721 online